These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9695225)

  • 21. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in cardiovascular risk factors and their treatment among patients discharged from divisions of internal medicine. The FAPOI-1 and FADOI-2 studies.
    Di Rosa S; Iori I; Vescovo G; Puddu PE; Lanti M; Menotti A
    Ital Heart J; 2003 Jul; 4(7):460-7. PubMed ID: 14558297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
    Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR; Engstrand S; Berglin E; Johnson O
    Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
    Nassiacos D; Meloni S
    Ital Heart J; 2005 May; 6 Suppl 1():51S-65S. PubMed ID: 15945300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure.
    Stefanidis I; Hägel J; Frank D; Maurin N
    Clin Nephrol; 1996 Sep; 46(3):199-205. PubMed ID: 8879856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Gao D; Ning N; Niu X; Hao G; Meng Z
    Heart; 2011 Feb; 97(4):278-86. PubMed ID: 21134903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
    Vasiuk IuA; Iushchuk EN; Shkol'nik EL; Khadzegova AB; Sadulaeva IA; Vit'ko NK; Vakhromeeva MN
    Ter Arkh; 2007; 79(2):51-8. PubMed ID: 17460970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of long-term Fraxiparin treatment on hemostasis in patients with primary pulmonary hypertension].
    Chazova IE; Panchenko EP; Dobrovol'skiĭ AB; Nakonechnikov SN; Titaeva EV; Baklanova NA; Belenkov IuN
    Ter Arkh; 1997; 69(9):62-6. PubMed ID: 9411832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
    Zaslavskaia RM; Kelimberdieva ES; Komissarova IA; Teĭblium MM; Goncharov LF; Goncharova ZF; Akhmetov KZh
    Ter Arkh; 1999; 71(11):58-61. PubMed ID: 10626340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relations between parameters of lipid metabolism and hemostasis in vascular diseases].
    Frick G; Frick U; Brachmann K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):511-8. PubMed ID: 6083921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of trimetazidine on heart rate variability in patients with heart failure.
    Gunes Y; Guntekin U; Tuncer M; Sahin M
    Arq Bras Cardiol; 2009 Aug; 93(2):154-8. PubMed ID: 19838493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic modulation in heart failure: high time for a definitive clinical trial.
    Ashrafian H; Neubauer S
    Heart; 2011 Feb; 97(4):267-8. PubMed ID: 21258118
    [No Abstract]   [Full Text] [Related]  

  • 40. [The dynamics of blood lipid composition in patients with ischemic heart disease in the process of multiple laser therapy combined with anaprilin and verapamil administration].
    Vasil'ev AP; Strel'tsova NN; Senatorov IuN; Mironova NA
    Klin Med (Mosk); 1997; 75(9):53-5. PubMed ID: 9432545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.